A Phase 2 interventional study of Drug-coated balloon angioplasty and stenting angioplasty in Vertebral Artery Stenosis, sponsored by The First Affiliated Hospital of Zhengzhou University. Status unknown at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-05-04.
Sponsored by The First Affiliated Hospital of Zhengzhou University · Phase 2, Interventional, and Treatment
Posterior circulation stroke accounts for 20% of ischemic stroke. A quarter occurs in patients with stenosis in the vertebral and/or basilar arteries. Vertebral artery stenosis can be treated with stenting. However, in-stent restenosis rate have been reported as high as more than 30%, which may reduce the effect of stent therapy. Drug-coated balloon has shown good results in controlling neointimal hyperplasia in the femoral and popliteal arteries.
20 studies on the registry are indexed under Vertebrobasilar Insufficiency; 8 are open to participants now.
This study's planned enrollment of 150 is above the median of 90 across 14 interventional studies indexed under Vertebrobasilar Insufficiency.
Browse Vertebrobasilar Insufficiency studies →The First Affiliated Hospital of Zhengzhou University is the lead sponsor of 123 studies on the registry; 72 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: Drug-coated balloon angioplasty
Device: stenting angioplasty
Angioplasty with a drug-coated angioplasty
Angioplasty with a stenting
Restenosis
Time frame: 12 months
The composite of vascular death, myocardial infarction, or any stroke
Time frame: within 30 days after the start of treatment
The composite of vascular death, myocardial infarction, or any stroke
Time frame: within 12 months after the start of treatment
Death resulting from any cause
Time frame: 12 months
Stroke in the supply territory of the symptomatic vertebral artery
Time frame: 12 months
Serious adverse events
Time frame: 30 days
This study is status unknown, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vertebrobasilar Insufficiency→
The First Affiliated Hospital of Zhengzhou University